Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mohammed Alnahedh"'
Autor:
Nora Alkhudair, Majed Alshamrani, Hadeel Samarkandi, Hajer Almodaheem, Hana Alabdulkarim, Mai Alsaqaaby, Fouad Alnajjar, Hashem Alhashem, Mohammed Bakkar, Shouki Bazarbashi, Mohammed Alnahedh, Feras Alfraih, Mohammad Alawagi, Ahmed Al-jedai
Publikováno v:
Saudi Pharmaceutical Journal, Vol 29, Iss 2, Pp 115-120 (2021)
Cancer is widely recognized as a major global health problem and is estimated to rank as one of the leading causes of death worldwide. Saudi Arabia has undergone remarkable socioeconomic development in the past 40 years which has contributed to the i
Externí odkaz:
https://doaj.org/article/abcd3f7b889a4b59afe9b1084389dcfb
Autor:
Aeshah A. AlAzmi, Wasil Jastaniah, Hani S. Alhamdan, Arwa O. AlYamani, Waleed I. AlKhudhyr, Shaker M. Abdullah, Mohammed AlZahrani, Ashraf AlSahafi, Tawfiq A. AlOhali, Trad Alkhelawi, Yasser AlObaida, Ayman Allam, Hani Al-Hashmi, Essam Murshid, Fouad AlNajjar, Ashwag AlGethami, Atika AlHarbi, Meteb O. AlFoheidi, Ahmad S. AlSaeed, Hassan Elsolh, Ibraheem Abosoudah, Abdulaziz Ben Obaid, Mohammed AlNahedh
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 476-485 (2020)
PURPOSE Cancer treatment shortages are complex and a persistent problem worldwide. Patients with cancer are most vulnerable to drug shortages, which provides opportunities to examine the extent of the challenge(s) facing Saudi Arabia and to provide r
Externí odkaz:
https://doaj.org/article/4d6bf81edff240d6a38d10d6c4906bb3
Autor:
Fouad AlNajjar, Hassan El-Solh, Arwa O AlYamani, Mohammed Alzahrani, Wasil Jastaniah, Waleed I AlKhudhyr, Hani Alhashmi, Hani Alhamdan, Ayman Allam, Trad Alkhelawi, Mohammed Alnahedh, Yasser AlObaida, Essam Murshid, Ibraheem Abosoudah, Tawfiq A AlOhali, Abdulaziz Ben Obaid, Atika M AlHarbi, Ashraf AlSahafi, Shaker Abdullah, Ashwag A Algethami, Meteb O AlFoheidi, Aeshah AlAzmi, Ahmad Alsaeed
Publikováno v:
JCO Global Oncology
PURPOSE Cancer treatment shortages are complex and a persistent problem worldwide. Patients with cancer are most vulnerable to drug shortages, which provides opportunities to examine the extent of the challenge(s) facing Saudi Arabia and to provide r
Autor:
Fouad AlNajjar, Amr Khardaly, Eshtyag Bajnaid, Aeshah AlAzmi, Abdulaziz Ben Obaid, Nora Alkhudair, Mohammed Alnahedh, Mansoor A Khan, Hadeel Samarkandi, Salman Alabdali, Majed Alshamrani, Atika M AlHarbi
Publikováno v:
Journal of Oncology Pharmacy Practice
Purpose During COVID-19 pandemic, cancer patients are considered one of the most vulnerable to infection since they tend to have advanced age, multiple comorbidities, and are often immunosuppressed by their cancer or therapy. Hence, the Saudi Oncolog
Autor:
Mohammad Alawagi, Ahmed Al-Jedai, Hajer Almodaheem, Fouad AlNajjar, Hana Alabdulkarim, Majed Alshamrani, Mohammed Alnahedh, Mai AlSaqa’aby, Hashem Alhashem, Hadeel Samarkandi, Feras Alfraih, Nora Alkhudair, Shouki Bazarbashi, Mohammed Bakkar
Publikováno v:
Saudi Pharmaceutical Journal, Vol 29, Iss 2, Pp 115-120 (2021)
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal : SPJ
Cancer is widely recognized as a major global health problem and is estimated to rank as one of the leading causes of death worldwide. Saudi Arabia has undergone remarkable socioeconomic development in the past 40 years which has contributed to the i
Autor:
Riad El Fakih, Nora Alkhudair, Ali Al-Ahmari, Hadeel Samarkandi, Mohammed Alnahedh, Ibrahim N. Muhsen
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 13, Iss 4, Pp 251-254 (2020)